Detection of high nerve growth factor serum levels in AIDS-related and -unrelated Kaposi's sarcoma patients

AIDS

Volumn 12, Issue 15, 1998, Pages 2025-2029

  Pica, Francesca ^a   Volpi, Antonio ^a   Barillari, Giovanni ^a   Fraschetti, Marzia ^a   Franzese, Ornella ^a   Vullo, Vincenzo ^b   Garaci, Enrico ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

HIV; Human herpesvirus 8; Kaposi's sarcoma; Nerve growth factor

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL COUNT; CELL GROWTH; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE TEST; KAPOSI SARCOMA; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SERUM; SPINDLE CELL;

EID: 0032558799     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199815000-00014     Document Type: Article

References (16)

1. Levi-Montalcini R, Angeletti PV: Immunosympathectomy. Pharmacol Rev 1966, 18:619-628.
2. Torcia M, Bracci Laudiero L, Lucibello M, et al.: Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996, 85: 345-356.
3. Bracci-Laudiero L, Aloe L, Levi-Montalcini R, et al.: Increased levels of NGF in sera of systemic lupus erythematosus patients. Neuroreport 1993, 4:563-565.
4. Shirai A, Cosentino M, Leitman-Klinman SF, et al.: Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest 1992, 89:561-566.
5. Vella S, Chiesi A, Volpi A et al.: Differential survival of patients with AIDS according to the 1987 and 1993 CDC Case definitions. JAMA 1994, 271:1197-1199.
6. Soderstrom S, Hallbook F, Ibanez CF, Persson H, Ebendal T: Recombinant human-nerve growth factor (NGF): biological activity and properties in an enzyme immunoassay. J Neurosci Res 1990, 27:665-677.
7. Kedes DH, Operskalski E, Bush M, et al.: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nature Med 1996, 2:918-924.
8. + T cells. Science 1988, 242:427-430.
9. Barillari G, Buonaguro L, Fiorelli V, et al.: Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 1992, 149:3727-3734.
10. Chang Y, Cesarman E, Pessin MS, et al.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
11. Moore PS and Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995, 332:1181-1185.
12. Gao SJ, Kingsley L, Li M, et al.: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996, 2:925-928.
13. Whitby D, Howard MR, Tenant-Flowers M, et al.: Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 364:799-802.
14. Ambroziak JA, Blackbourn DJ, Herndier BG, et al.: Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995, 268:582-583.
15. Mesri EA, Cesarman E, Arvanitakis E, et al.: Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996, 183:2385-2390.
16. Levy JA: A new human herpesvirus: KSHV or HHV8? Lancet 1995, 34:786.